期刊文献+

血清新蝶呤检测对登革病毒感染的早期评估 被引量:2

Detection of Serum Neopterin for Early Assessment of Dengue Virus Infection
下载PDF
导出
摘要 目的探讨血清新蝶呤检测在登革病毒感染早期诊断中的潜在应用价值。方法检测110例登革热(DF)病人血中新蝶呤的含量,将其与50份水痘病人和40份流感病人血中新蝶呤的含量进行比较,155份来自健康献血员的血清作为对照。结果急性期登革热病人血中新蝶呤的平均含量为48.2nmol/L,高于水痘病人、流感病人和健康对照者血中的平均含量(分别为36.3nmol/L、18.8nmol/L和6.7nmol/L,P<0.001)。在已经确诊的登革热病人中,症状出现第一天即可检测到血中新蝶呤含量升高,且在病程第四天升至最大值54.3nmol/L。血中新蝶呤含量升高的水平与热程相关,因而可以用来确定病程长短。结论登革热病人血中新蝶呤含量较健康对照者以及其它病毒感染者显著升高(P<0.001),可以作为早期确定登革热严重程度的指标。 Objective To discuss the potential value of neopterin in early prognostic information of dengue virus infection. Method Neopterin concentrations were determined in serum samples from 110 severe acute dengue fever(DF) patients. The neoptefin levels were compared with those in 50 respiratory syndrome measles and 40 influenza patients; 155 healthy blood donors served as controls. Result In sera of acute DF patients mean neopterin concentration was 48.2 nmol/L, higher than that in patients with measles (36.3 nmol/L) and influenza (18.8 nmol/L) and in control group (6.7 nmol/L; P 〈 0.001). In the patients with confirmed DF, an early neoptefin elevation was detected on the first day after the onset of symptoms and rose to a maximum level of 54.3 nmol/L 4 days after the onset. Higher increase of neopterin level in DF patients was associated with longer duration of fever and thus predicted the clinical course of the disease. Conclusion Neopterin concentrations, showing significantly higher in DF patients than that in control group and people with other viral infections (P 〈 0.001 ) and may allow early assessment of the severity of DF.
出处 《热带医学杂志》 CAS 2006年第12期1264-1267,共4页 Journal of Tropical Medicine
关键词 登革病毒 新蝶呤 登革热 dengue virus Neopterin dengue fever
  • 相关文献

参考文献16

  • 1HENCHAL EA,PUTNAK JR.The dengue viruses[J].Clin Microbiol Rev,1990,3(4):376-396.
  • 2HALSTEAD SB.Immunological parameters of togaviras disease sydromes[M].In:Schlesinger RW,editor.The toga viruses.New York:Academic Press,1980:107-173.
  • 3HALSTEAD SB.The XXth century dengue pandemic:need for surveillance and research[J].World Health Stat Q,1992,45 (2-3):292-298.
  • 4KRISHNAMURTI C,ALVING B.Effect of dengue virus on procoagulant and fibrinolytic activities of monocytes[J].Rev Infect Dis,1989,11 (4):843-846.
  • 5SHEKHAR KC,HUAT OL.Epidemiology of dengue/dengue hemorrhagic fever in malaysiaea retrospective epidemiological study 1973 e 1987.Part Ⅰ:Dengue hemorrhagic fever (DHF)[J].Asia Pac J Public Health,1992,6(2):15-25.
  • 6HALSTEAD SB.Pathogenesis of dengue:challenges to molecular biology[J].Science,1988,239 (4839):476-481.
  • 7KURANE I,ENNIS FA.Immunopathogenesis of dengue virus infections[M].In:Gubler DJ,Kuno G,editors.Dengue and dengue haemorrhagic fever.London:CAB International,1997:273-290.
  • 8HAYES EB,GUBLER DJ.Dengue and dengue hemorrhagic fever[J].Pediatr Infect Dis J,1992,11(4):311-317.
  • 9COSGRIFF TM.Mechanisms of disease in hantavirus infection:pathophysiology of hemorrhagic fever with renal syndrome[J].Rev Infect Dis,1991,13:97-107.
  • 10NATHAN CF.Secretory products of macrophages[J].J Clin Invest,1987,79(2):319-326.

同被引文献35

  • 1梁绍伶,黎学铭,董柏青,谭毅,梁富雄.广西SARS来源的流行病学研究[J].热带医学杂志,2006,6(6):694-695. 被引量:2
  • 2王丽芳,张朋卫,刘永春,张晋霞,赵聚辉.血清新喋呤检测在急性胰腺炎中的意义[J].河北医科大学学报,2007,28(1):9-11. 被引量:2
  • 3FOUCHIER RA,KUIKEN T,SCHUTYEN M,et al.Aetiology:Koch's postulates fulfilled for SARS virus[J].Nature,2003,423:240.
  • 4FUCHS D,HAUSEN A,REIBNEGGER G,et al.Neopterin as a marker for activated cell-mediated irmnunity application in HIV infection[J].Immunol Today,1988,9:150-155.
  • 5FAHEY JL,TAYLOR JM,DETELS R,et al.The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1[J].N Engl J Med,1990,322:166-172.
  • 6REIBNEGGER G,AICHBERGER C,Fuchs D,et al.Posttransplant neopterin excretion in renal allograft recipients-a reliable diagnostic aid for acute rejection and a predictive marker of long-term graft survival[J].Transplantation,1991,52:58-63.
  • 7WORLD HEALTH ORGANIZATION,Case Definitions for Surveillance of Severe Acute Respiratory Syndrome(SARS),World Health Organization,Geneva,Switzerland,2003(Accessed at www.who.int/csr/sars/casedefinition/en/on 25 February 2004).
  • 8ZHONG NS,ZHENG BJ,LI YM,et al.Epidemiology and cause of severe acute respiratory syndrome(SARS)in Guangdong[J].Lancet,2003,362:1353-1358.
  • 9GUAN Y,ZHENG BJ,HE YQ,et al.Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China[J].Science,2003,302:276-278.
  • 10ZANGERLE R,SCHOENITZER D,FUCHS D,et al.Reducing HIV transmission by seronegative blood[J].Lancet,2003,339:130-131.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部